drugset / Trial / NCT07101965

Phase I Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RSS0343 Tablets in Healthy Subjects After Single and Multiple Oral Administration and the Effect of Food on the Pharmacokinetics of RSS0343

NCT07101965

Phase 1 Completed 72 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the safety and tolerability of RSS0343 tablets in healthy subjects after single and multiple oral administration

Timeline

Start
2024-04-07
Primary completion
2024-11-06
Completion
2024-11-06

Drugs

EvaluationDrugModalityDoseRoute
Subject RSS0343 Unknown Oral

Indications

No indication recorded.